Perfil da empresa · Healthcare

Progyny Inc

PGNY · EUA
País / Região
USA
Data do IPO
25 de outubro de 2019
Funcionários
835
Buffett Score
43/100
Fraco
Valor de mercadoUS$ 1,94 bi
Receita (TTM)US$ 1,31 bi
EBITDAUS$ 125,57 mi
Margem líquida6%
ROE16,24%
P/L (TTM)27,42
P/L projetado11,85
LPAUS$ 0,92
Faixa de 52 semanasUS$ 16,10 – US$ 33,07
Preço-alvo dos analistasUS$ 34,42
Recomendação dos analistas4.6 / 5

Dados da EODHD, apresentados na moeda de reporte; apenas para referência, não constitui recomendação de investimento.

Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services, as well as pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions. In addition, it provides assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

História

Em breveEsta seção está sendo preenchida — volte em breve.

Posição no setor

Em breveEsta seção está sendo preenchida — volte em breve.

Ainda não há análises sobre este ativo no seu idioma.